Analysis of cellular localization of РН domain of Bcr-Abl with USP1 protein and development of software for estimation of their phosphorylation sites

  • S. V. Antonenko
  • D. S. Gurianov
  • I. V. Kravchuk
  • G. D. Telegeev


Aim. This work was dedicated to investigation of cellular localization РН domain of Bcr-Abl with USP1 protein and to develop useful tool to aggregate information about protein phosphorylation sites. Methods. Mammalian cell transfection. Primers design. Widefield and STED fluorescent microscopy. Basic software development in Python. Results. Co-localization between USP1 and PH domain of Bcr-Abl has been detected. Primers for main domains of USP1 have been designed. Integration tool phospho-aggregate has been developed. Super-resolution image of intracellular distribution of PH domain of Bcr was obtained. Conclusions. Nuclear localization of USP1 in 293T cells and also point co-localizations of USP1 and РН domain of Bcr-Abl oncoloprotein show strong association of investigated proteins with specific cellular structures. Identification of these cellular structures can help to find out biological functions of of USP1 in CML. Tool phospho-aggregate can be used to simplify analysis and comparison of protein phosphorylation sites. Subdiffraction imaging of intracellular distribution of PH domain of Bcr shows that it clusters in structures that resemble shape of clathrin-coated vesicles.
Keywords: Bcr-Abl, USP1, PH domain, cortactin, cellular localization, phosphorylation sites.


Miroshnychenko D., Dubrovska A., Maliuta S., Telegeev G., Aspenström P. Novel role of pleckstrin homology domain of the Bcr-Abl protein: Analysis of protein-protein and protein-lipid interactions. Exp Cell Res. 2010. Vol. 316(4). P. 530–542. doi: 10.1016/j.yexcr.2009.11.014

Jalkanen S., Lahesmaa-Korpinen A., Heckman C. Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients. Experimental hematology. 2012. Vol. 40 (9). P. 705–714. e3. doi: 10.1016/j.exphem.2012.05.010

Deininger M.W., Goldman J.M., Melo J.V. The molecular biology of chronic myeloid leukemia. Blood. 2000. Vol. 96. P. 3343–3356.

García-Santisteban I., Peters G.J, Giovannetti E., Rodríguez J.A. USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy. Molecular Cancer. 2013. Vol. 12. P. 9. doi: 10.1186/1476-4598-12-913.

Fraile J.M., Quesada V., Rodriguez D., Freije J.M., Lopez-Otin C. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene. 2012. Vol. 31. P. 2373–2388. doi: 10.1038/onc.2011.443

Cotto-Rios X.M., Jones M.J.K., Huang T.T. Insights into phosphorylation-dependent mechanisms regulating USP1protein stability during the cell cycle. Cell Cycle. 2011. Vol. 10 (23). P. 4009–4016. doi: 10.4161/cc.10.23.18501

Gatesman A.A., Weed S.A. Cortactin Branches Out: Roles in Regulating Protrusive Actin Dynamics. Cell Motil Cytoskeleton. 2008. Vol. 65, № 9. P. 687–707. doi: 10.1002/cm.20296

Weed S.A., Parsons J.T. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene. 2001. Vol. 20. P. 6418–6434. doi: 10.1038/sj.onc.1204783

Gurianov D.S., Antonenko S.V., Kravchuk I.V., Telegeev G.D. Cellular localization of b-tubulin, cortactin and PH domain of Bcr, and their potential role in signalling pathways and clathrin-mediated endocytosis. 12th International Congress of Cell Biology Abstract Book. 2016. P. 154.

Hornbeck P., Zhang B., Murray B., Kornhauser J., Atham V., Skrzypek E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Research. 2015. Vol. 43 (D1). P. D512–D520. doi: 10.1093/nar/gku1267

Dinkel H., Chica C., Via A., Gould C., Jensen L., Gibson T., Diella F. Phospho.ELM: a database of phosphorylation sites – update 2011. Nucleic Acids Research. 2011. Vol. 39 (Database). P. D261–D267. doi: 10.1093/nar/gkq1104

Gnad F., Ren S., Cox J., Olsen J.V., Macek B., Oroshi M., Mann M. PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biology. 2007. Vol. 8. P. R250. doi: 10.1186/gb-2007-8-11-r250

Gnad F., Gunawardena J., Mann M. PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Research. 2011. Vol. 39. P. D253–D260. doi: 10.1093/nar/gkq1159

Horn H., Schoof E.M., Kim J., Robin X., Miller M.L., Diella F., Palma A., Cesareni G., Jensen L.J., Linding R. KinomeXplorer: an integrated platform for kinome biology studies. Nature Methods. 2014. Vol. 11 (6). P. 603–604. doi: 10.1038/nmeth.2968

Xue Y., Ren J., Gao X., Jin C., Wen L., Yao X. GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy. Mol Cell Proteomics. 2008. Vol. 7. P. 1598–1608. doi: 10.1074/mcp.M700574-MCP200

Antonenko S.V., Gurianov D.S., Telegeev G.D. Colocalization of USP1 and PH domain of Bcr-Abl oncoprotein in terms of chronic myeloid leukemia cell rearrangements. Cytology and Genetics. 2016. Vol. 50(4). P. 11–15. doi: 10.3103/S0095452716050029